Congress Weighs Repeal of Tax Credit for Rare Disease Drugs Long untouchable, the incentive for development of orphan drugs is now a Republican target as lawmakers consider a broad tax overhaul. Share: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook Related Posts:Chemical Industry Ally Faces Critics in Bid for Top E.P.A. PostIslands Seek International Funding for Hurricane RecoveryThe 2017 Hurricane Season Really Is More Intense Than NormalVolcano near Brit holiday hotspot is becoming ‘MORE DANGEROUS’ as fears of eruption growCaribbean Braces for Maria: ‘When Will All of the Hurricanes Stop?’U.S. Governors at U.N. Assembly: ‘You Have Allies’ on Climate Change
